missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 30171781

Carbonic Anhydrase IX/CA9 Antibody (girentuximab-MMAE) [Janelia Fluor™ 635], Novus Biologicals™

Human Monoclonal Antibody

Brand:  Novus Biologicals (Bio-Techne) NBP3-28523JF635

Product Code. 30171781

  • 3900.00 NOK / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

Carbonic Anhydrase IX/CA9 Monoclonal antibody specifically detects Carbonic Anhydrase IX/CA9 in Human samples. It is validated for Flow Cytometry,ELISA,Functional Assay
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Carbonic Anhydrase IX/CA9
Monoclonal
Janelia Fluor 635
CAIX, CA-IX, Carbonate dehydratase IX, carbonic anhydrase 9, carbonic anhydrase IX, carbonic dehydratase, EC 4.2.1.1, G250, Membrane antigen MN, MN, P54/58N, PMW1, RCC-associated antigen G250, RCC-associated protein G250, Renal cell carcinoma-associated antigen G250
CA9/ CAIX
0.1 mL
Cancer, HIF Target Genes, Hypoxia, Lipid and Metabolism, Metastasis, Renal Cell Carcinoma Cell Markers
768
Store at 4°C in the dark.
IgG1
Flow Cytometry, ELISA, Functional Assay
girentuximab-MMAE
50mM Sodium Borate
Human
Protein A purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.